RiDYMO®
— Hit Discovery Platform
About RiDYMO®
Harnessing the AI for Science paradigm, our multidisciplinary team addresses emerging trends in small molecule and biologics drug design. Through our cutting-edge drug design and computing platform, Hermite®, we aim to innovate in targeting the 'undruggables', pushing the boundaries of drug discovery.
Solutions
Our computational platform combines physics and AI to unlock new possibilities for structure and dynamics-based drug discovery. Utilizing Uni-Fold for protein folding and the RiD (Reinforced Dynamics) method for enhanced sampling, our platform enables high-resolution refinement of protein structures and accurate capture of intermediate states. This approach facilitates the identification of novel binding pockets and is applicable to a wide range of emerging therapeutic classes. Our dedicated team is actively engaged in:
